These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10678294)

  • 1. A review of pathophysiology and therapy of patients with vasovagal syncope.
    White CM; Tsikouris JP
    Pharmacotherapy; 2000 Feb; 20(2):158-65. PubMed ID: 10678294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome.
    Theodorakis GN; Markianos M; Zarvalis E; Livanis EG; Flevari P; Kremastinos DT
    J Am Coll Cardiol; 2000 Jul; 36(1):174-8. PubMed ID: 10898430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin reuptake inhibition for the prevention of vasovagal syncope: a systematic review and meta-analysis.
    Raj P; Lei L; Flevaris P; Raj S; Sheldon R
    Clin Auton Res; 2023 Dec; 33(6):811-819. PubMed ID: 37971641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy of neurocardiogenic syncope.
    Cadman CS
    Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syncope: pathophysiology, diagnosis, and pharmacotherapy.
    Lazarus JC; Mauro VF
    Ann Pharmacother; 1996 Sep; 30(9):994-1005. PubMed ID: 8876862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-up tilt test with clomipramine challenge in vasovagal syndrome--a new tilt testing protocol.
    Theodorakis GN; Livanis EG; Leftheriotis D; Flevari P; Markianos M; Kremastinos DT
    Eur Heart J; 2003 Apr; 24(7):658-63. PubMed ID: 12657224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasovagal syncope: asystole provoked by head-up tilt testing under sertraline therapy.
    Lenk MK; Alehan D; Ozme S; Celiker A; Ozer S
    Turk J Pediatr; 1997; 39(4):573-7. PubMed ID: 9433163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced plasma catecholamine and cAMP response during the head-up tilt test in patients with vasovagal syncope.
    Mitro P; Rybárová E; Zemberová E; Tkác I
    Wien Klin Wochenschr; 2005 May; 117(9-10):353-8. PubMed ID: 15989115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity.
    Flevari P; Leftheriotis D; Repasos E; Katsaras D; Katsimardos A; Lekakis J
    Europace; 2017 Jan; 19(1):127-131. PubMed ID: 27702846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormonal profile before and after beta-blockade in patients with neurocardiogenic syncope.
    Roul G; Riehl-Aleil V; Germain P; Bareiss P
    Pacing Clin Electrophysiol; 1999 Jul; 22(7):1020-30. PubMed ID: 10456630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing.
    Nakagawa H; Kobayashi Y; Kikushima S; Shinohara M; Obara C; Zinbo Y; Chiyoda K; Miyata A; Tanno K; Baba T; Katagiri T
    Jpn Circ J; 1998 Oct; 62(10):727-32. PubMed ID: 9805252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis.
    Forleo C; Guida P; Iacoviello M; Resta M; Monitillo F; Sorrentino S; Favale S
    Int J Cardiol; 2013 Sep; 168(1):27-35. PubMed ID: 23041006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope.
    Aerts A; Dendale P; Strobel G; Block P
    Am Heart J; 1997 May; 133(5):504-7. PubMed ID: 9141371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of vasovagal syncope.
    Atiga WL; Rowe P; Calkins H
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):874-86. PubMed ID: 10376927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of paroxetine in the treatment of refractory vasovagal syncope in young patients].
    Di Girolamo E; Di Iorio C; Leonzio L; Sabatini P; Ranalli G; Barsotti A
    G Ital Cardiol; 1999 Dec; 29(12):1472-7. PubMed ID: 10687110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the serotonergic system in the genesis of vasovagal syncope.
    Alboni P; Bondanelli M; Dinelli M; Gruppillo P; Franceschetti P; Marchi P; degli Uberti EC
    Europace; 2000 Apr; 2(2):172-80. PubMed ID: 11225944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the peripheral serotoninergic system in the pathogenesis of vasovagal syncope.
    Mitro P; Hijova E; Mudrakova K
    Bratisl Lek Listy; 2006; 107(6-7):248-52. PubMed ID: 17051902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of heart rate variability during the head-up tilt test in patients with vasovagal syncope].
    Mitro P; Rybár R
    Vnitr Lek; 2002 Apr; 48(4):314-9. PubMed ID: 12061181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.